Source: The Lancet
Date: July 2010.
Author: Chris Beyrer, Kasia Malinowska-Sempruch, Adeeba Kamarulzaman, Michel Kazatchkine, Michel Sidibe, Steffanie A Strathdee
The published work on HIV in people who use drugs shows that the global burden of HIV infection in this group can be reduced. Concerted action by governments, multilateral organizations, health systems, and individuals could lead to enormous benefits for families, communities, and societies.
The authors of this paper review the evidence and identify synergies between biomedical science, public health, and human rights. Cost-effective interventions, including needle and syringe exchange programs, opioid substitution therapy, and expanded access to HIV treatment and care are supported on public health and human rights grounds; however, only around 10 percent of people who use drugs worldwide are being reached, and far too many are imprisoned for minor off ences or detained without trial.
To change this situation will take commitment, advocacy, and political courage to advance the action agenda. Failure to do so will exacerbate the spread of HIV infection, undermine treatment programs, and continue to expand prison populations with patients in need of care.
The article is available below in English and Japanese. Chinese, Farsi, French, Polish, Russian, and Spanish versions will also be added.
Relevant drug policy publications are almost nonexistent in languages other than English. With the help of leading experts, the Open Society Foundations Global Drug Policy Program is publishing key documents in translation.
Download .pdf file